Razelle Kurzrock
Hematology & Oncology · Milwaukee, WINPI 1477651651
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $187,381 of the $199,421 with a category attached, or 94.0%. F. Hoffmann-la Roche AG accounts for 63.4% of it on its own, with 15 other manufacturers making up the rest. Among hematology & oncology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 61 payments — averaging $3269.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- F. Hoffmann-la Roche AG$127K
- Roche Diagnostics International Ltd$23K
- Daiichi Sankyo Inc.$9K
- Pfizer$9K
- Recordati_rare_diseases_inc.$8K
- Boehringer Ingelheim International GmbH$6K
- plus $19K from 10 others
Across 123 payments — averaging $15,703 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Foundation Medicine, Inc.$611K
- Konica Minolta Healthcare Americas, Inc$300K
- Boehringer Ingelheim International GmbH$267K
- EMD Serono, Inc.$212K
- Genentech, Inc.$204K
- Takeda Pharmaceuticals U.S.A., Inc.$130K
- plus $207K from 3 others
What the payments were for
- Consulting fees$187,38194%
- Speaking & faculty fees$11,2426%
- Travel & lodging$2880%
- Food & beverage$4970%
- Gifts$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| F. Hoffmann-la Roche AG | 17 | $126,505 |
| Roche Diagnostics International Ltd | 11 | $22,801 |
| Daiichi Sankyo Inc. | 10 | $8,743 |
| Pfizer(2 entities) | 3 | $8,610 |
| Recordati_rare_diseases_inc. | 4 | $7,530 |
| Boehringer Ingelheim International GmbH | 1 | $6,090 |
| EMD Serono, Inc. | 2 | $5,700 |
| Roche Diagnostics Corporation | 1 | $3,468 |
| Merck | 4 | $3,000 |
| GSK | 1 | $2,600 |
| Eisai Inc. | 1 | $1,875 |
| Tempus AI, Inc | 2 | $1,233 |
| Foundation Medicine, Inc. | 1 | $1,000 |
| Stemline Therapeutics Inc. | 1 | $149 |
| Sun Pharmaceutical Industries Inc. | 1 | $105 |
| Sysmex America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sylvant$7,530
- Enhertu$6,808
- Non-Covered Product$3,588
- Perjeta$3,132
- Halaven$1,875
- KEYTRUDA$1,500
- FOUNDATIONONE LIQUID$1,000
- FOUNDATIONFOCUS$1,000
- FOUNDATIONONE CDX$1,000
- FOUNDATIONONE HEME$1,000
- FOUNDATIONONE$1,000
- ELZONRIS$149
- ILUMYA$105
How this compares
$199,421 in reported general payments places this provider in the 95th percentile of 248 hematology & oncology providers in Wisconsin.
Other hematology & oncology in Milwaukee
- Parameswaran HariMilwaukee$1.3M
- Sayed Mehdi HamadaniMilwaukee$546K
- Binod DhakalMilwaukee$535K
- Deepak KilariMilwaukee$359K
- Ehab AtallahMilwaukee$344K
- Nirav ShahMilwaukee$207K
- Syed AbutalibMilwaukee$154K
- Patrick FoyMilwaukee$132K
- Guru Subramanian Guru MurthyMilwaukee$113K
- Renju Vechurettu RajMilwaukee$96K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.